MAPS PBC

MAPS Public Benefit Corporation (MAPS PBC) is the ‘benefit above profit’ corporation that is fully owned by MAPS.

MAPS PBC

MAPS PBC was established in 2014 and is a hybrid between a non-profit and for-profit business. It aims for profit, pays taxes, but aims to serve the public to the fullest.

In December 2021, MAPS and Vine Ventures announced the creation of a novel, social impact Special Purpose Vehicle (SPV), called the Regenerative Financing Vine (RFV), that will infuse $70 million into patient access infrastructure and research for MDMA-assisted therapy for PTSD. This model fully maintains both MAPS’ nonprofit mission and governance and MAPS PBC public benefit drug development and post-approval activities.  

“MAPS Public Benefit Corporation (MAPS PBC) catalyzes healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics prioritizing public benefit above profit. Founded in 2014, MAPS PBC is a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS) a 501(c)(3) nonprofit.”

The MAPS therapy training program, among other things, is a thing that MAPS PBC does.

News

• Numinus and MAPS Public Benefit Corporation Announce Collaboration Agreement to Seek Approval of MDMA-Assisted Psychotherapy for PTSD Single-Arm, Open-Label Trial (press release, December 2020)